Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13837)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2015 (publication date) through Mar 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Singh P, Staller K, Barshop K, Dai E, Newman J, Yoon S, Castel S, Kuo B. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. World J Gastroenterol 2015; 21(26): 8103-8109 [PMID: 26185382 DOI: 10.3748/wjg.v21.i26.8103] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i26/8103.htm |
| Number | Citing Articles |
| 1 |
Sarah Ballou, Courtney McMahon, Ha-Neul Lee, Jesse Katon, Andrea Shin, Vikram Rangan, Prashant Singh, Judy Nee, Michael Camilleri, Anthony Lembo, Johanna Iturrino. Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey. Clinical Gastroenterology and Hepatology 2019; 17(12): 2471 doi: 10.1016/j.cgh.2019.08.016
|
| 2 |
Shoaib Ahmed Kashani. Prevalence and Characterization of Antibiotic Resistance Food Borne Pathogens Isolated from Locally Produced Chicken Raw Meat and their Handlers. Journal of Psychology & Clinical Psychiatry 2017; 7(6) doi: 10.15406/jpcpy.2017.07.00458
|
| 3 |
Xinyu Fan, Jiachen Shi, Ye Liu, Mengqiu Zhang, Min Lu, Ding Qu. Cannabidiol-Decorated Berberine-Loaded Microemulsions Improve IBS-D Therapy Through Ketogenic Diet-Induced Cannabidiol Receptors Overexpression. International Journal of Nanomedicine 2023; : 2839 doi: 10.2147/IJN.S402871
|
| 4 |
Sujit S Sansgiry. A Cost-Effectiveness Comparison of Alosetron, Eluxadoline, and Rifaximin in the Treatment of Irritable Bowel Syndrome with Diarrhea. Pharmacy & Pharmacology International Journal 2016; 4(6) doi: 10.15406/ppij.2016.04.00095
|
| 5 |
Joelle BouSaba, Wassel Sannaa, Sanna McKinzie, Priya Vijayvargiya, Victor Chedid, Xiao Jing Wang, Jessica Atieh, Ting Zheng, Justin Brandler, Ann L. Taylor, Irene Busciglio, W. Scott Harmsen, Michael Camilleri. Impact of Bile Acid Diarrhea in Patients With Diarrhea-Predominant Irritable Bowel Syndrome on Symptoms and Quality of Life. Clinical Gastroenterology and Hepatology 2022; 20(9): 2083 doi: 10.1016/j.cgh.2021.11.035
|
| 6 |
Gordon Crawford, Rory Taylor, David Young, Chris G. Hatton, Naohisa Yoshida. Efficacy of the Enteroadsorbent Silicol®gel in Adults with Irritable Bowel Syndrome Subtypes IBS-D or Mixed: Observational Open-Label Study. Gastroenterology Research and Practice 2023; 2023: 1 doi: 10.1155/2023/3432763
|
| 7 |
Jing Li, WingYi Ng, YongKang Liu, XiaoKun Fang, ZhongQiu Wang, LiXia Pei, XueHu Wei. Neuroplasticity of the white matter tracts underlying recovery of diarrhea-predominant irritable bowel syndrome following acupuncture treatment. Frontiers in Neuroscience 2024; 18 doi: 10.3389/fnins.2024.1383041
|
| 8 |
Maha Gamal Ramadan Asal, Ahmed Abdelwahab Ibrahim El-Sayed, Samira Ahmed Alsenany, Zahraa Hassan Ramzy, Rasha Fathy Ahmed Dawood. Self-administered active versus sham acupressure for diarrhea predominant irritable bowel syndrome: a nurse-led randomized clinical trial. BMC Nursing 2025; 24(1) doi: 10.1186/s12912-024-02594-5
|
| 9 |
Xiao-Fei Chen, Yun Guo, Xing-Qi Lu, Le Qi, Kuang-Hui Xu, Yong Chen, Guo-Xiong Li, Jian-Ping Ding, Jie Li. Aberrant Intraregional Brain Activity and Functional Connectivity in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Frontiers in Neuroscience 2021; 15 doi: 10.3389/fnins.2021.721822
|
| 10 |
|
| 11 |
Yuanfang Chen, Baotao Lian, Peize Li, Simeng Yao, Zhengkun Hou. Studies on irritable bowel syndrome associated with anxiety or depression in the last 20 years: A bibliometric analysis. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.947097
|
| 12 |
Claire A.M. Zar‐Kessler, Jaime Belkind‐Gerson, Suzanne Bender, Braden M. Kuo. Treatment of Functional Abdominal Pain With Antidepressants. Journal of Pediatric Gastroenterology and Nutrition 2017; 65(1): 16 doi: 10.1097/MPG.0000000000001416
|
| 13 |
Esther Colomier, Joost Algera, Chloé Melchior. Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.629026
|
| 14 |
Tian-Ran Zhou, Jing-Jing Huang, Zi-Tong Huang, Hong-Ying Cao, Bo Tan. Inhibitory effects of patchouli alcohol on stress-induced diarrhea-predominant irritable bowel syndrome. World Journal of Gastroenterology 2018; 24(6): 693-705 doi: 10.3748/wjg.v24.i6.693
|
| 15 |
Edward Young, Laura S Rojas Vasquez, Amanda Lim, Hamish Philpott. Low FODMAP diet for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2022; 2022(8) doi: 10.1002/14651858.CD014029
|
| 16 |
Yijie Li, Xiaolan Su, Peng Wu, Jifeng Wang, Yu Guo, Jiajie Zhu, Qingguo Wang, Jiande Chen, Fuquan Yang, Wei Wei. Proteomics analysis of IBS-D with spleen and kidney yang deficiency. Journal of Traditional Chinese Medical Sciences 2017; 4(1): 39 doi: 10.1016/j.jtcms.2017.05.006
|
| 17 |
Lucy Doyle, Tina Cartwright. Yoga use, physical and mental health, and quality of life in adults with irritable bowel syndrome: A mixed-methods study. European Journal of Integrative Medicine 2023; 62: 102270 doi: 10.1016/j.eujim.2023.102270
|
| 18 |
Tudor‐Ștefan Rotaru, Ovidiu Cristian Frățilă, Oana Bărboi, Irina Ciortescu, Cătălina Mihai, Carmen Anton, Gabriela Ștefănescu, Vasile Drug. A comparison using standardized measures for patients with irritable bowel syndrome: Trust in the gastroenterologist and reliance on the internet. Neurogastroenterology & Motility 2021; 33(5) doi: 10.1111/nmo.13977
|
| 19 |
Yan Chen, Fuhao Chu, Jie Lin, Zeqi Su, Mengting Liao, Tao Li, Yuan Li, Nadia Johnson, Haocheng Zheng, Xia Ding. The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies. Journal of Ethnopharmacology 2021; 275: 114119 doi: 10.1016/j.jep.2021.114119
|
| 20 |
Nobuo Fuke, Koichi Aizawa, Hiroyuki Suganuma, Tomohisa Takagi, Yuji Naito. Effect of combined consumption ofLactobacillus brevisKB290 andβ-carotene on minor diarrhoea-predominant irritable bowel syndrome-like symptoms in healthy subjects: a randomised, double-blind, placebo-controlled, parallel-group trial. International Journal of Food Sciences and Nutrition 2017; 68(8): 973 doi: 10.1080/09637486.2017.1311843
|
| 21 |
Prashant Singh, Gregory Sayuk, David Rosenbaum, Susan Edelstein, Kenji Kozuka, Lin Chang. An Overview of the Effects of Tenapanor on Visceral Hypersensitivity in the Treatment of Irritable Bowel Syndrome with Constipation. Clinical and Experimental Gastroenterology 2024; : 87 doi: 10.2147/CEG.S454526
|
| 22 |
Olga Bednarska, Olga Biskou, Hans Israelsen, Martin E. Winberg, Susanna Walter, Åsa V. Keita. A postbiotic fermented oat gruel may have a beneficial effect on the colonic mucosal barrier in patients with irritable bowel syndrome. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1004084
|
| 23 |
L. Quénéhervé, D. Drui, J. Blin, M. Péré, E. Coron, G. Barbara, M. R. Barbaro, B. Cariou, M. Neunlist, D. Masson, K. Bach-Ngohou. Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87158-2
|
| 24 |
Prashant Singh, Ha-Neul Lee, Vikram Rangan, Sarah Ballou, Joseph Lembo, Jesse Katon, Courtney McMahon, Daniel Friedlander, Johanna Iturrino, Judy Nee, Anthony Lembo. Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea. Clinical Gastroenterology and Hepatology 2020; 18(2): 399 doi: 10.1016/j.cgh.2019.08.020
|
| 25 |
Christopher J Martoni, Shalini Srivastava, Anders Damholt, Gregory J Leyer. Efficacy and dose response of <i>Lactiplantibacillus plantarum</i> in diarrhea-predominant irritable bowel syndrome. World Journal of Gastroenterology 2023; 29(28): 4451-4465 doi: 10.3748/wjg.v29.i28.4451
Abstract(981) |
Core Tip(849) |
Full Article(HTML)(6307)
|
Full Article with Cover (PDF)-2006K(232)
|
Full Article (Word)-377K(56)
|
Audio-408K(16)
|
Peer-Review Report-355K(107)
|
Answering Reviewers-69K(107)
|
Supplementary Material-146K(115)
|
Full Article (PDF)-1647K(441)
|
Full Article (XML)-167K(98)
|
Times Cited (11)
|
Total Visits (14162)
|
Open
|
| 26 |
Christopher J. Black, Yan Yiannakou, Lesley A. Houghton, Farag Shuweihdi, Robert West, Elspeth Guthrie, Alexander C. Ford. Anxiety‐related factors associated with symptom severity in irritable bowel syndrome. Neurogastroenterology & Motility 2020; 32(8) doi: 10.1111/nmo.13872
|
| 27 |
Jennifer Jones, Anthony Lembo, Joel Heidelbaugh, Louis Kuritzky, Brian Lacy. Management of irritable bowel syndrome with diarrhea: focus on eluxadoline. Current Medical Research and Opinion 2021; 37(4): 567 doi: 10.1080/03007995.2021.1888705
|
| 28 |
Maura Corsetti, Peter Whorwell. The global impact of IBS: time to think about IBS-specific models of care?. Therapeutic Advances in Gastroenterology 2017; 10(9): 727 doi: 10.1177/1756283X17718677
|
| 29 |
Robert James Trager, Shaffer R.S. Mok, Kayla J. Schlick, Jaime A. Perez, Jeffery A. Dusek. Association between radicular low back pain and constipation: a retrospective cohort study using a real-world national database. PAIN Reports 2021; 6(3): e954 doi: 10.1097/PR9.0000000000000954
|
| 30 |
Vivek C. Goodoory, Elspeth A. Guthrie, Cho E. Ng, Christopher J. Black, Alexander C. Ford. Factors associated with lower disease‐specific and generic health‐related quality of life in Rome IV irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2023; 57(3): 323 doi: 10.1111/apt.17356
|
| 31 |
Inês A. Trindade, Chloé Melchior, Hans Törnblom, Magnus Simrén. Quality of life in irritable bowel syndrome: Exploring mediating factors through structural equation modelling. Journal of Psychosomatic Research 2022; 159: 110809 doi: 10.1016/j.jpsychores.2022.110809
|
| 32 |
K Van Malderen, J.G. De Man, B.Y. De Winter, H.U. De Schepper. Epidemiological characteristics of a population visiting a patient-centered informative website about irritable bowel syndrome. Acta Gastro Enterologica Belgica 2023; 86(1): 17 doi: 10.51821/86.1.10885
|
| 33 |
J. BouSaba, S. Dilmaghani, A. Taylor, I. Busciglio, S. McKinzie, M. Camilleri. Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome. Gastro Hep Advances 2023; 2(5): 623 doi: 10.1016/j.gastha.2023.02.009
|
| 34 |
Sula Windgassen, Rona Moss-Morris, Hazel Everitt, Alice Sibelli, Kimberley Goldsmith, Trudie Chalder. Cognitive and Behavioral Differences Between Subtypes in Refractory Irritable Bowel Syndrome. Behavior Therapy 2019; 50(3): 594 doi: 10.1016/j.beth.2018.09.006
|
| 35 |
Xiuxiu Wei, Yongtian Wen, Yuchen Wei, Xu Liang, Xiangxue Ma, Beihua Zhang, Xudong Tang. External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: A systematic review and meta-analysis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.940328
|
| 36 |
Hester Bowers, David Gillanders, Nuno Ferreira. Moderating effect of IBS acceptance on psychosocial mediators of Irritable Bowel Syndrome. Journal of Contextual Behavioral Science 2020; 16: 30 doi: 10.1016/j.jcbs.2020.02.004
|
| 37 |
Chloé Melchior, Esther Colomier, Inês A. Trindade, Mahrukh Khadija, Jóhann P. Hreinsson, Hans Törnblom, Magnus Simrén. Irritable bowel syndrome: Factors of importance for disease‐specific quality of life. United European Gastroenterology Journal 2022; 10(7): 754 doi: 10.1002/ueg2.12277
|
| 38 |
Paul Enck, Qasim Aziz, Giovanni Barbara, Adam D. Farmer, Shin Fukudo, Emeran A. Mayer, Beate Niesler, Eamonn M. M. Quigley, Mirjana Rajilić-Stojanović, Michael Schemann, Juliane Schwille-Kiuntke, Magnus Simren, Stephan Zipfel, Robin C. Spiller. Irritable bowel syndrome. Nature Reviews Disease Primers 2016; 2(1) doi: 10.1038/nrdp.2016.14
|
| 39 |
Christopher J. Black, Alexander C. Ford. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nature Reviews Gastroenterology & Hepatology 2020; 17(8): 473 doi: 10.1038/s41575-020-0286-8
|
| 40 |
Lin Chang, Shahnaz Sultan, Anthony Lembo, G. Nicholas Verne, Walter Smalley, Joel J. Heidelbaugh. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation. Gastroenterology 2022; 163(1): 118 doi: 10.1053/j.gastro.2022.04.016
|
| 41 |
K. N. Khalaidzheva, V. N. Drozdov, E. V. Shikh, S. Yu. Serebrova. The place of antispasmodic drugs in modern therapy of irritable bowel syndrome. Meditsinskiy sovet = Medical Council 2023; (8): 189 doi: 10.21518/ms2023-127
|
| 42 |
Kyoungmi Jung, Areum Kim, Ji-Hae Lee, Donghyun Cho, Juyeon Seo, Eun Sung Jung, Hye-ji Kang, Jonghwa Roh, Wangi Kim. Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients 2022; 14(10): 2015 doi: 10.3390/nu14102015
|
| 43 |
S.A. Sukhanova, A.Yu. Timakova, M.A. Livzan, M.M. Fedorin, Yu.P. Skirdenko, O.V. Gaus, K.A. Andreev, A.V. Gorbenko, M.I. Plinder. Adherence to treatment of patients with irritable bowel syndrome: state of the issue. Profilakticheskaya meditsina 2021; 24(8): 101 doi: 10.17116/profmed202124081101
|
| 44 |
Zahra A. Barandouzi, Jie Chen, Wendy A. Henderson, Angela R. Starkweather, Xiaomei S. Cong. Nurse-led self-management support to improve symptom management and self-reported outcomes in people with irritable bowel syndrome. Interdisciplinary Nursing Research 2024; 3(3): 163 doi: 10.1097/NR9.0000000000000069
|
| 45 |
V. V. Tsukanov, A. V. Vasyutin, Ju. L. Tonkikh. Efficacy of probiotics for the treatment of irritable bowel syndrome. Meditsinskiy sovet = Medical Council 2022; (15): 119 doi: 10.21518/2079-701X-2022-16-15-119-126
|
| 46 |
Brooks D. Cash, Mark Pimentel, Satish S. C. Rao, Leonard Weinstock, Lin Chang, Zeev Heimanson, Anthony Lembo. Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial. Therapeutic Advances in Gastroenterology 2017; 10(9): 689 doi: 10.1177/1756283X17726087
|
| 47 |
Olga Biskou, Susanna Walter, Hans Israelsen, Martin E. Winberg, Olga Bednarska, Åsa V. Keita. ReFerm®: a postbiotic fermented oat gruel composition is reducing mast cell degranulation in the colon of patients with irritable bowel syndrome. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1408623
|
| 48 |
Anthony Lembo, Shahnaz Sultan, Lin Chang, Joel J. Heidelbaugh, Walter Smalley, G. Nicholas Verne. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea. Gastroenterology 2022; 163(1): 137 doi: 10.1053/j.gastro.2022.04.017
|
| 49 |
Md. Khalid Anwer, Mohammed Muqtader Ahmed, Mohammed F. Aldawsari, Muzaffar Iqbal, Gamal A. Soliman, Ibrahim A. Aljuffali. Eluxadoline-Loaded Eudragit Nanoparticles for Irritable Bowel Syndrome with Diarrhea: Formulation, Optimization Using Box–Behnken Design, and Anti-Diarrheal Activity. Pharmaceutics 2023; 15(5): 1460 doi: 10.3390/pharmaceutics15051460
|
| 50 |
LeeAnne B. Sherwin, Emily Leary, Wendy A. Henderson. Effect of Illness Representations and Catastrophizing on Quality of Life in Adults With Irritable Bowel Syndrome. Journal of Psychosocial Nursing and Mental Health Services 2016; 54(9): 44 doi: 10.3928/02793695-20160803-01
|
| 51 |
Mengmeng Zhang, Xu Wu, Huanqing Gao, Lin Zhang, Yao Li, Min Li, Chongbo Zhao, Peifeng Wei, Li Ou. Chinese Herbal Medicine for Irritable Bowel Syndrome: A Perspective of Local Immune Actions. The American Journal of Chinese Medicine 2024; 52(07): 2079 doi: 10.1142/S0192415X24500800
|
| 52 |
Yudianita Kesuma, Rini Sekartini, Ina S. Timan, Agnes Kurniawan, Saptawati Bardosono, Agus Firmansyah, Yvan Vandenplas. Irritable bowel syndrome in Indonesian adolescents. Jornal de Pediatria 2021; 97(2): 197 doi: 10.1016/j.jped.2020.02.001
|
| 53 |
Eric D. Shah, Brian E. Lacy, William D. Chey, Lin Chang, Darren M. Brenner. Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials. American Journal of Gastroenterology 2021; 116(8): 1601 doi: 10.14309/ajg.0000000000001313
|
| 54 |
Christopher J Black, Nicholas E Burr, Michael Camilleri, David L Earnest, Eamonn MM Quigley, Paul Moayyedi, Lesley A Houghton, Alexander C Ford. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis. Gut 2020; 69(1): 74 doi: 10.1136/gutjnl-2018-318160
|
| 55 |
Weiqun Ao, Yougen Cheng, Mingxian Chen, Fuquan Wei, Guangzhao Yang, Yongyu An, Fan Mao, Xiandi Zhu, Guoqun Mao. Intrinsic brain abnormalities of irritable bowel syndrome with diarrhea: a preliminary resting-state functional magnetic resonance imaging study. BMC Medical Imaging 2021; 21(1) doi: 10.1186/s12880-020-00541-9
|
| 56 |
Darren M Brenner, Gregory S Sayuk, Jessica L Abel, Kate Burslem. Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide. Journal of Managed Care & Specialty Pharmacy 2021; 27(4): 469 doi: 10.18553/jmcp.2021.27.4.469
|
| 57 |
Yang Liu, Xinjie Yu, Leilei Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Long Qian, Qun Wang, Zhengqing Xue, Qixiao Zhai, Wei Chen. Lactobacillus plantarum CCFM8610 Alleviates Irritable Bowel Syndrome and Prevents Gut Microbiota Dysbiosis: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Trial. Engineering 2021; 7(3): 376 doi: 10.1016/j.eng.2020.06.026
|
| 58 |
Wei Ke, Jinjun Wu, Hongbin Li, Siyu Huang, Huibiao Li, Yongfu Wang, Yingxiu Wu, Jie Yuan, Shuncong Zhang, Hongmei Tang, Kaijun Lei. Network pharmacology and experimental validation to explore the mechanism of Changji'an formula against irritable bowel syndrome with predominant diarrhea. Heliyon 2024; 10(12): e33102 doi: 10.1016/j.heliyon.2024.e33102
|
| 59 |
Xiaofang Lu, Shengsheng Zhang, Cheng Yang, Zhengfang Wang, Luqing Zhao, Zhenyu Wu, Jing Xie, Jieyun Yin. Effect of TongXie‐YaoFang on Cl− and HCO3 - Transport in Diarrhea‐Predominant Irritable Bowel Syndrome Rats. Evidence-Based Complementary and Alternative Medicine 2016; 2016(1) doi: 10.1155/2016/7954982
|
| 60 |
Kristen R. Weaver, Gail D’Eramo Melkus, Jason Fletcher, Wendy A. Henderson. Perceived Stress, Its Physiological Correlates, and Quality of Life in Patients With Irritable Bowel Syndrome. Biological Research For Nursing 2018; 20(3): 312 doi: 10.1177/1099800418756733
|
| 61 |
Mengdi Jia, Xiaofang Lu, Zhengfang Wang, Luqing Zhao, Shengsheng Zhang. Effects of Fengliao-Changweikang in Diarrhea-predominant Irritable Bowel Syndrome Rats and Its Mechanism Involving Colonic Motility. Journal of Neurogastroenterology and Motility 2018; 24(3): 479 doi: 10.5056/jnm17093
|
| 62 |
Jessica L. Abel, Robyn T. Carson, David A. Andrae. The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea. Quality of Life Research 2019; 28(2): 369 doi: 10.1007/s11136-018-2008-z
|
| 63 |
Prashant Singh, Judy Nee. Role of Diet in Diarrhea-predominant Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2021; 55(1): 25 doi: 10.1097/MCG.0000000000001445
|
| 64 |
Elizabeth Dent, Nicola Davinson, Stephanie Wilkie. The impact of gastrointestinal conditions on psychosocial factors associated with the biopsychosocial model of health: A scoping review. Applied Psychology: Health and Well-Being 2022; 14(2): 626 doi: 10.1111/aphw.12323
|
| 65 |
Adelina Nicoleta Galica, Reitano Galica, Dan Lucian Dumitrașcu. Diet, fibers, and probiotics for irritable bowel syndrome. Journal of Medicine and Life 2022; 15(2): 174 doi: 10.25122/jml-2022-0028
|
| 66 |
Claire J. Han, Ken Pike, Monica E. Jarrett, Margaret M. Heitkemper. Symptom‐based latent classes of persons with irritable bowel syndrome. Research in Nursing & Health 2019; 42(5): 382 doi: 10.1002/nur.21974
|
| 67 |
LeeAnne Sherwin, Onyinyechi Ozoji, Christina Boulineaux, Paule Joseph, Nicolaas Fourie, Sarah Abey, Xuemin Zhang, Wendy Henderson. Gender and Weight Influence Quality of Life in Irritable Bowel Syndrome. Journal of Clinical Medicine 2017; 6(11): 103 doi: 10.3390/jcm6110103
|